Craft

Orbital Therapeutics

Total Funding

$270 M

Orbital Therapeutics Summary

Company Summary

Overview
Orbital Therapeutics is a biotechnology company that develops ribonucleic acid (RNA) medicine to treat diseases in humans. Its platform designs RNA technology for an expansive portfolio of medicine, including vaccines, immunomodulation, protein replacement, and regenerative medicine.
Type
Private
Status
Active
Founded
2022
HQ
Cambridge, MA, US | view all locations
Website
https://orbitaltx.com
Cybersecurity rating
Sectors

Key People

  • Gilles Besin

    Gilles Besin, Chief Scientific Officer

  • Niru Subramanian

    Niru Subramanian, Chief Operating Officer

  • Jonathan Piazza

    Jonathan Piazza, Chief Financial Officer

  • Kristina Burow

    Kristina Burow, Co-Founder & Director

LocationsView all

2 locations detected

  • Cambridge, MA HQ

    United States

    21 Erie Street

  • South San Francisco, CA

    United States

    2 Tower Place, 18th Floor

Footer menu